Skip to main content
Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
53.51
-1.60 (-2.90%)
At close: Apr 28, 2026, 4:00 PM EDT
52.73
-0.78 (-1.46%)
After-hours: Apr 28, 2026, 7:31 PM EDT

Bio-Techne Revenue

Bio-Techne had revenue of $295.88M in the quarter ending December 31, 2025, a decrease of -0.39%. This brings the company's revenue in the last twelve months to $1.22B, up 1.64% year-over-year. In the fiscal year ending June 30, 2025, Bio-Techne had annual revenue of $1.22B with 5.23% growth.

Revenue (ttm)
$1.22B
Revenue Growth
+1.64%
P/S Ratio
6.89
Revenue / Employee
$392,122
Employees
3,100
Market Cap
8.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20251.22B60.58M5.23%
Jun 30, 20241.16B22.36M1.97%
Jun 30, 20231.14B31.10M2.81%
Jun 30, 20221.11B174.57M18.75%
Jun 30, 2021931.03M192.34M26.04%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Halozyme Therapeutics 1.40B
Arrowhead Pharmaceuticals 1.09B
Axsome Therapeutics 638.50M
Krystal Biotech 389.13M
ImmunityBio 113.29M
Cytokinetics 88.04M
Kymera Therapeutics 39.21M
Praxis Precision Medicines 7.46M
Revenue Rankings

TECH News

More News